Trial intelligence / Profile preview

Suppository naproxen for prevention of acute pancreatitis

IRCT201105301155N14Phase 3Completed

Sponsor
Behvazan
Start
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of naproxen in acute pancreatitis (AP), sponsored by Behvazan. Started Feb 2013; status: completed.

02

Drugs

naproxen
03

Conditions

acute pancreatitis (AP)

Beyond the preview

Go deeper on IRCT201105301155N14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201105301155N14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call